ATE424188T1 - Isotone fettemulsionen - Google Patents

Isotone fettemulsionen

Info

Publication number
ATE424188T1
ATE424188T1 AT02748862T AT02748862T ATE424188T1 AT E424188 T1 ATE424188 T1 AT E424188T1 AT 02748862 T AT02748862 T AT 02748862T AT 02748862 T AT02748862 T AT 02748862T AT E424188 T1 ATE424188 T1 AT E424188T1
Authority
AT
Austria
Prior art keywords
isotone
fat emulsions
organs
tissues
cell membranes
Prior art date
Application number
AT02748862T
Other languages
English (en)
Inventor
Yvon Carpentier
Isabelle Dupont
Original Assignee
Target Hit Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Target Hit Sa filed Critical Target Hit Sa
Application granted granted Critical
Publication of ATE424188T1 publication Critical patent/ATE424188T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02748862T 2001-07-25 2002-07-20 Isotone fettemulsionen ATE424188T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01117991A EP1279400A1 (de) 2001-07-25 2001-07-25 Änderung der Fettsäurezusammensetzung Organ- und Gewebe-Zellmembranen

Publications (1)

Publication Number Publication Date
ATE424188T1 true ATE424188T1 (de) 2009-03-15

Family

ID=8178132

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02748862T ATE424188T1 (de) 2001-07-25 2002-07-20 Isotone fettemulsionen

Country Status (10)

Country Link
US (1) US7560486B2 (de)
EP (2) EP1279400A1 (de)
JP (1) JP2005501828A (de)
CN (1) CN1267085C (de)
AT (1) ATE424188T1 (de)
CA (1) CA2454665C (de)
DE (1) DE60231406D1 (de)
ES (1) ES2324526T3 (de)
IL (1) IL160012A0 (de)
WO (1) WO2003009828A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20012384A1 (it) * 2001-11-12 2003-05-12 Quatex Nv Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
US20050164908A1 (en) * 2004-01-23 2005-07-28 Ginsberg Myron D. Neuroprotective complex for treatment of cerebral ischemia and injury
US20070149617A1 (en) 2005-11-14 2007-06-28 Deckelbaum Richard J Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs
PE20070999A1 (es) * 2005-12-09 2007-09-28 Drugtech Corp Emulsion de acido graso esencial intravenosa
PL1800675T4 (pl) 2005-12-23 2012-02-29 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
US20070212470A1 (en) * 2006-03-13 2007-09-13 Nutracea Therapeutic uses of an anti-cancer composition derived from rice bran
WO2008036353A2 (en) 2006-09-19 2008-03-27 The Trustees Of Columbia University In The City Of New York Omega-3 diglyceride emulsions
US8652508B2 (en) 2007-05-25 2014-02-18 Children's Medical Center Corporation Dietary formulations and methods for treatment of inflammation and other disorders
JP5711968B2 (ja) 2007-10-03 2015-05-07 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ 高エイコサペンタエン酸を生成するためのヤロウィア・リポリティカ（ＹａｒｒｏｗｉａＬｉｐｏｌｙｔｉｃａ）の最適化株
US8618056B2 (en) 2007-12-22 2013-12-31 Cuthbert O. Simpkins Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
US8906855B2 (en) 2007-12-22 2014-12-09 Vivacelle Bio, Inc. Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
US8063020B2 (en) 2007-12-22 2011-11-22 Simpkins Cuthbert O Resuscitation fluid
WO2010005961A2 (en) 2008-07-07 2010-01-14 Pentech Health, Inc. Nutritive compositions and methods of using same
US9532963B2 (en) * 2009-03-09 2017-01-03 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US20110071090A1 (en) * 2009-03-11 2011-03-24 Stable Solutions Llc Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
US8241672B2 (en) 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
GB2489163A (en) 2010-01-04 2012-09-19 Pentec Health Inc Nutritive compositions and methods of using same
WO2011103510A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha ester emulsions
WO2011103512A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha free fatty acid emulsions
WO2011103514A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha triglyceride emulsions
EP2717680A1 (de) 2011-06-09 2014-04-16 Lifeline Scientific, Inc. Datenaufzeichnung für organtransport und/oder -lagerung mit biomarker- und ereignisinformationen
CN107028926A (zh) * 2011-08-26 2017-08-11 国立大学法人大阪大学 糖尿病性心血管并发症的预防/治疗剂
WO2013142482A1 (en) 2012-03-20 2013-09-26 Particle Dynamics International, Llc Gelling agent-based dosage form
US9629820B2 (en) 2012-12-24 2017-04-25 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
US10123986B2 (en) 2012-12-24 2018-11-13 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
EP2958559A4 (de) * 2013-02-20 2016-07-20 Univ Columbia Verwendung einer omega-3-emulsion auf lipidbasis zum schutz von organen vor ischämischer läsion
US10420337B2 (en) 2013-03-15 2019-09-24 Lifeline Scientific, Inc. Transporter with a glucose sensor for determining viability of an organ or tissue
US20140278468A1 (en) 2013-03-15 2014-09-18 I.D. Therapeutics Llc Apparatus and method for optimizing treatment using medication compliance patterns and glucose sensor
CN105263321B (zh) 2013-03-28 2018-07-27 哥伦比亚大学纽约管理委员会 用omega-3甘油酯再灌注促进对用于移植的供体器官的保护
EP3071524A1 (de) 2013-11-22 2016-09-28 General Electric Company Fettsäure-biodispergiermittel und verfahren zur verwendung
US10328045B2 (en) 2014-09-12 2019-06-25 Children's Medical Center Corporation, Inc. Dietary emulsion formulations and methods for using the same
CN106667910B (zh) * 2017-01-12 2021-02-02 西南大学 一种谷维素鱼油纳米乳液及其制备方法和应用
PT3664628T (pt) * 2017-08-10 2024-12-31 Childrens Medical Ct Corp Métodos e composições relacionados com emulsões compreendendo óleo de peixe e/ou ácidos gordos ómega-3
EP4181876A1 (de) * 2020-07-14 2023-05-24 Nutrition Lipid Developments Isotonische lipidemulsion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6049747A (ja) * 1983-08-29 1985-03-19 Sanyuu Shoji Kk リン脂質組成物
DE3721137A1 (de) * 1987-06-26 1989-01-05 Dietl Hans Fettemulsion zur intravenoesen anwendung
DE3734147C2 (de) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung
DE3903057A1 (de) 1989-02-02 1990-08-09 Braun Melsungen Ag Fettemulsion zur endotrachealen applikation, ihre herstellung und anwendung
DE3903056A1 (de) 1989-02-02 1990-08-09 Braun Melsungen Ag Fettemulsion zur intraperitonealen applikation, ihre herstellung und anwendung
US5089268A (en) * 1990-05-02 1992-02-18 Katz David P Egg phosphatide lipid emulsions altered for a specific therapeutic fatty acid composition
SE9101642D0 (sv) * 1991-05-30 1991-05-30 Kabi Pharmacia Ab Phospholipids
WO1997019683A1 (en) 1995-11-28 1997-06-05 B. Braun Melsungen Ag Hydrolysis-optimized lipid emulsions and use thereof

Also Published As

Publication number Publication date
ES2324526T3 (es) 2009-08-10
US20040247693A1 (en) 2004-12-09
CN1267085C (zh) 2006-08-02
IL160012A0 (en) 2004-06-20
EP1408931B1 (de) 2009-03-04
CA2454665A1 (en) 2003-02-06
US7560486B2 (en) 2009-07-14
EP1408931A1 (de) 2004-04-21
CN1553798A (zh) 2004-12-08
WO2003009828A1 (en) 2003-02-06
DE60231406D1 (de) 2009-04-16
EP1279400A1 (de) 2003-01-29
JP2005501828A (ja) 2005-01-20
CA2454665C (en) 2011-10-11

Similar Documents

Publication Publication Date Title
DE60231406D1 (de) Isotone Fettemulsionen
AR000995A1 (es) Composicion que comprende una dispersion de vesiculas lipidas con un nucleo acuoso y/o vesiculas lipidas con un nucleo oleoso, y procedimiento para eltratamiento no-terapeutico de la piel mediante dicha composicion.
DE60135333D1 (de) Tiernahrung sowie verfahren
DK1681945T3 (da) Humanmodermælkslipid-mimetikum som kosttilskud
DE60114606D1 (de) Ausgewogene lipidzusammensetzung enthaltende eier
EP1537069A4 (de) ANALOGA VON OMEGA-3-PUFAs ABGELEITETEN LIPIDMEDIATOREN UND ANWENDUNGSVERFAHREN
WO2008005869A3 (en) Infant formulas for early brain development
CY1111808T1 (el) Συνθεσεις εχουσες αποτελεσματα προληψης ή βελτιωσης καταστασεων ή νοσων που προκαλουνται απο εγκεφαλικη υπολειτουργια
ATE549014T1 (de) Prostaglandin-fettemulsion, verfahren zu ihrer herstellung, verfahren zu ihrer stabilisierung und emulgierendes mittel
BR9903434A (pt) Composição cosmética e/ou dermatológica na forma de uma emulsão óleo-em-água, método de tratamento cosméticos, uso da composição e uso cosmético da composição
WO2003099830A3 (en) Cardiolipin compositions, methods of preparation and use
ATE297974T1 (de) Verfahren zur reinigung von an omega-3-fettsäuren angereichertem meeressäugetieröl und dessen zusammensetzungen
PT920323E (pt) Nova utilizacao de fosfolipidos de origem animal em terapeutica e/ou dietetica
NO20076382L (no) Anvendelse av dokosaheksaenglyserider i behandlingen av tumorese sykdommer
ATE167983T1 (de) Phospholipidhaltige fettmischung mit lcp- fettsäuren
BR0309089A (pt) Métodos dietéticos para melhoria de desempenho em cães
DE60218481D1 (de) Lipid mischungen und lebensmittel, enthaltend ölsäure und omega-6 fettsäuren, die die intramyozelluläre lipidkonzentration erhöhen
PE20070999A1 (es) Emulsion de acido graso esencial intravenosa
CR6807A (es) Subtipos de almidon y metabolismo de lipidos
BRPI0401751B1 (pt) Pacote de agente tensoativo e emulsão de água-em-hidrocarboneto utilizando o mesmo
TW200612834A (en) Acidic oil-in-water emulsion composition
Zimmer et al. n-3 polyunsaturated fatty acid deficiency and dopamine metabolism in the rat frontal cortex
WO1999066922A8 (en) Method of altering nutritional components of milk produced by a lactating animal
FI980961A0 (fi) Menetelmä märehtijän maito- ja/tai kudosrasvan konjugoidun linolihaponpitoisuuden nostamiseksi
RU2052947C1 (ru) Масложировой продукт, имеющий иммуностимулирующие свойства

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1408931

Country of ref document: EP